Drug Topics October 2022

From biosimilars to artificial intelligence, these are the trends poised to take community pharmacy by storm.

Patients with metabolic syndrome and diabetes may be experiencing challenges outside medication management.

In an ideal world, pharmacists would be able to spot patients in mental health crisis and provide appropriate solutions.

Mavacamten improves functional capacity and symptoms in adults with New York Heart Association class II-III obstructive HCM.

As he prepared to move house, our columnist was struck by the similarities between a yard sale and the prescription drug pricing infrastructure.